U.S. flag

An official website of the United States government

NM_000190.4(HMBS):c.940_941del (p.Gln314fs) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Apr 3, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001229602.6

Allele description

NM_000190.4(HMBS):c.940_941del (p.Gln314fs)

Gene:
HMBS:hydroxymethylbilane synthase [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
11q23.3
Genomic location:
Preferred name:
NM_000190.4(HMBS):c.940_941del (p.Gln314fs)
Other names:
p.Gln314Valfs*8
HGVS:
  • NC_000011.10:g.119093135CA[1]
  • NG_008093.1:g.13259CA[1]
  • NM_000190.4:c.940_941delMANE SELECT
  • NM_001024382.2:c.889_890del
  • NM_001258208.2:c.820_821del
  • NM_001258209.2:c.769_770del
  • NP_000181.2:p.Gln314fs
  • NP_001019553.1:p.Gln297fs
  • NP_001245137.1:p.Gln274fs
  • NP_001245138.1:p.Gln257fs
  • LRG_1076t1:c.940_941del
  • LRG_1076t2:c.889_890del
  • LRG_1076:g.13259CA[1]
  • LRG_1076p1:p.Gln314fs
  • LRG_1076p2:p.Gln297fs
  • NC_000011.9:g.118963845CA[1]
  • NC_000011.9:g.118963845_118963846del
  • NM_000190.3:c.940_941del
Protein change:
Q257fs
Links:
dbSNP: rs1407093112
NCBI 1000 Genomes Browser:
rs1407093112
Molecular consequence:
  • NM_000190.4:c.940_941del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001024382.2:c.889_890del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258208.2:c.820_821del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001258209.2:c.769_770del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001402053Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 9, 2021)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV004226629Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 3, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Citations

PubMed

Two deletion mutations in the hydroxymethylbilane synthase gene in two unrelated Japanese patients with acute intermittent porphyria.

Maeda N, Horie Y, Adachi K, Nanba E, Kawasaki H, Daimon M, Kudo Y, Kondo M.

J Hum Genet. 2000;45(4):263-8.

PubMed [citation]
PMID:
10944860

Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.

Ulbrichova D, Schneider-Yin X, Mamet R, Saudek V, Martasek P, Minder EI, Schoenfeld N.

Blood Cells Mol Dis. 2009 Mar-Apr;42(2):167-73. doi: 10.1016/j.bcmd.2008.11.001. Epub 2009 Jan 12.

PubMed [citation]
PMID:
19138865
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV001402053.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This variant is present in population databases (no rsID available, gnomAD 0.003%). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the HMBS protein in which other variant(s) (p.Gln328Valfs*30) have been determined to be pathogenic (PMID: 10944860, 19138865). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 956739). This premature translational stop signal has been observed in individuals with AIP (PMID: 30740734; Invitae). This sequence change creates a premature translational stop signal (p.Gln314Valfs*8) in the HMBS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 48 amino acid(s) of the HMBS protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV004226629.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)

Description

PP4, PM2, PVS1_strong

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 1, 2024